Issue Date: January 17, 2025
Issued by: Oncology Center of Excellence
Topic(s):
Status: Draft
Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology
This guidance provides recommendations to sponsors for the clinical development of drug and biological products intended for the prevention and treatment of chemotherapy-induced peripheral neuropathy in oncology patient populations. The guidance pertains to development programs for drugs regulated by the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research.
Download the Guidance Document
